C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study

Y. van Durme, K. Verhamme, G. Van Pottelberge, J. Witteman, A. Uitterlinden, G. Joos, A. Hofman, G. Brusselle, B. Stricker (Ghent, Belgium; Rotterdam, Netherlands)

Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD
Session: Genetic risk factors for asthma and COPD
Session type: Oral Presentation
Number: 2761
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. van Durme, K. Verhamme, G. Van Pottelberge, J. Witteman, A. Uitterlinden, G. Joos, A. Hofman, G. Brusselle, B. Stricker (Ghent, Belgium; Rotterdam, Netherlands). C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study. Eur Respir J 2008; 32: Suppl. 52, 2761

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
C-reactive protein levels and the risk of COPD in a general population: the Rotterdam study
Source: Annual Congress 2007 - Mechanisms and new treatments of COPD
Year: 2007


The study on the association of serum C-reactive protein level with the risk of lung cancer
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009


Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity.
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Is there a relationship between severity of COPD and C-reactive protein (CRP) levels?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006

The association of C-reactive protein, serum amyloid-A and fibrinogen with prevalent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 506s
Year: 2001

High-sensitive C-reactive protein is associated with reduced lung function in young adults
Source: Eur Respir J 2009; 33: 382-388
Year: 2009



LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021

Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

PP302 – The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Source: ERS Lung Science Conference 2021
Year: 2021

C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

Genetic determinants of C-reactive protein in COPD
Source: Eur Respir J 2006; 28: 1156-1162
Year: 2006



Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006

C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012


Variations in C-reactive protein gene and COPD: tagging SNPs analysis in case-control study
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007


Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia?
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Prognosis value of initial C-reactive protein (CRP) assay in patients with community acquired pneumonia
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008


Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Source: Eur Respir J 2008; 32: 1451-1457
Year: 2008



The polymorphisms of C-reactive protein gene modify the association between central obesity, asthma and lung function in Taiwan
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011

Association between C-reactive protein levels and outcome in acute lung injury in children
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011